LFCR — LIFECORE BIOMEDICAL, INC. \DE\

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1005286 ·
Last close
$6.39
Market Cap
$242.22M
52W High
$8.98
52W Low
$3.63
ADV30
446,362
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 25,322,000 6,826,000 -894,000 -40,084,000 228,303,000 23,035,000 301,707,000
Jun 2026 34,167,000 12,075,000 2,567,000 -6,156,000 229,500,000 17,241,000 263,594,000
Mar 2026 23,193,000 4,462,000 -4,672,000 -14,980,000 225,499,000 20,795,000 253,937,000
Sep 2025 31,109,000 7,791,000 -3,067,000 -9,991,000 235,204,000 18,856,000 245,741,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$11,219,000
Investing CF
$-4,280,000
Financing CF
$-2,736,000
CapEx
$-4,280,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.99
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-284,421,000
Inventory
$27,695,000
Receivables
$31,347,000
ST Investments
—
EBIT TTM
$-41,178,000
Pretax Income TTM
$-70,761,000
Interest Exp TTM
$29,583,000
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$106,460,592
EBITDA
$4,168,287
Free Cash Flow
—
Enterprise Value
$431,353,184
Total Cash
$23,035,000
Total Debt
$162,179,008
Shares Out
37,905,846
Trailing EPS
$-1.27
Book Value
$-1.94
ROE
—
ROA
—
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 — — — 232,177,000 246,379,000 -14,202,000 —
May 2025 128,867,000 -12,006,000 -38,717,000 239,342,000 238,006,000 1,336,000 -206,000
May 2024 128,261,000 -7,188,000 12,013,000 253,960,000 242,645,000 11,315,000 257,000
May 2023 103,269,000 -19,720,000 -99,563,000 253,545,000 257,775,000 -4,230,000 -17,441,000
May 2022 111,270,000 -3,432,000 -116,715,000 — — — -22,593,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$229,500,000
Forward EPS
$-0.78

Max Pain — expiry 2026-12-18

max pain strike: $5.00 · spot: $6.40 · call oi: 2,140 · put oi: 658
Expected Move to 2026-12-18: ±$1.15 (17.97%) — implied range $5.25 – $7.55 · ATM straddle on $7.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
PRE Prenetics Global Ltd $248.19M $16.33 —
RCKT ROCKET PHARMACEUTICALS, INC. $235.60M $2.11 —
BIOA BioAge Labs, Inc. $234.35M $5.10 —
NWBO NORTHWEST BIOTHERAPEUTICS INC $250.73M $0.15 —
CAMP Camp4 Therapeutics Corp $251.02M $4.00 —

News headlines (Yahoo Finance, 1h cache)

Lifecore Biomedical: Q3 Earnings Snapshot
2026-11-04 12:27 · Yahoo
Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update
2026-11-04 12:05 · Yahoo
Is Lifecore Biomedical (LFCR) an Asymmetric Risk-Reward in Pharma Contract Manufacturing?
2026-10-23 17:34 · Yahoo
Lifecore Biomedical to Participate at Upcoming Industry Conferences
2026-10-07 20:05 · Yahoo
Lifecore Biomedical to be Acquired by Webster Equity Partners
2026-09-28 12:45 · Yahoo
Lifecore Biomedical to Participate at CPHI Global Conference
2026-09-03 20:05 · Yahoo
Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
2026-09-02 11:05 · Yahoo
Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity
2026-08-17 15:29 · Yahoo
Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript
2026-08-12 15:31 · Yahoo
Lifecore Biomedical Inc (LFCR) (Q2 2026) Earnings Call Highlights: Strategic Wins and Capacity ...
2026-08-05 19:04 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.